ChemoCentryx, Inc. 4
4 · ChemoCentryx, Inc. · Filed Nov 20, 2014
Insider Transaction Report
Form 4
Duliege Anne-Marie
EVP, Chief of Strategic Dev.
Transactions
- Sale
Common Stock
2014-11-18$4.71/sh−4,970$23,432→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $4.60 to $4.86 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Includes 4,970 shares acquired under the Issuer's Employee Stock Purchase Plan on November 14, 2014.